Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1963 1
1967 3
1968 3
1969 1
1972 1
1974 2
1975 1
1976 1
1977 3
1978 4
1979 2
1980 3
1981 3
1982 3
1984 5
1985 11
1986 5
1987 9
1988 8
1989 18
1990 14
1991 22
1992 11
1993 19
1994 17
1995 9
1996 9
1997 6
1998 17
1999 16
2000 26
2001 10
2002 21
2003 11
2004 13
2005 19
2006 16
2007 16
2008 22
2009 35
2010 29
2011 33
2012 29
2013 23
2014 22
2015 28
2016 21
2017 17
2018 32
2019 28
2020 26
2021 29
2022 34
2023 21
2024 18

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

744 results

Results by year

Filters applied: . Clear all
Page 1
Oral HDAC inhibitor tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: phase IIb results.
Rai S, Kim WS, Ando K, Choi I, Izutsu K, Tsukamoto N, Yokoyama M, Tsukasaki K, Kuroda J, Ando J, Hidaka M, Koh Y, Shibayama H, Uchida T, Yang DH, Ishitsuka K, Ishizawa K, Kim JS, Lee HG, Minami H, Eom HS, Kurosawa M, Lee JH, Lee JS, Lee WS, Nagai H, Shindo T, Yoon DH, Yoshida S, Gillings M, Onogi H, Tobinai K. Rai S, et al. Among authors: kurosawa m. Haematologica. 2023 Mar 1;108(3):811-821. doi: 10.3324/haematol.2022.280996. Haematologica. 2023. PMID: 36200417 Free PMC article.
Effect of Recent Antirheumatic Drug on Features of Rheumatoid Arthritis-Associated Lymphoproliferative Disorders.
Hoshida Y, Tsujii A, Ohshima S, Saeki Y, Yagita M, Miyamura T, Katayama M, Kawasaki T, Hiramatsu Y, Oshima H, Murayama T, Higa S, Kuraoka K, Hirano F, Ichikawa K, Kurosawa M, Suzuki H, Chiba N, Sugiyama T, Minami Y, Niino H, Ihata A, Saito I, Mitsuo A, Maejima T, Kawashima A, Tsutani H, Takahi K, Kasai T, Shinno Y, Tachiyama Y, Teramoto N, Taguchi K, Naito S, Yoshizawa S, Ito M, Suenaga Y, Mori S, Nagakura S, Yoshikawa N, Nomoto M, Ueda A, Nagaoka S, Tsuura Y, Setoguchi K, Sugii S, Abe A, Sugaya T, Sugahara H, Fujita S, Kunugiza Y, Iizuka N, Yoshihara R, Yabe H, Fujisaki T, Morii E, Takeshita M, Sato M, Saito K, Matsui K, Tomita Y, Furukawa H, Tohma S. Hoshida Y, et al. Among authors: kurosawa m. Arthritis Rheumatol. 2024 Jun;76(6):869-881. doi: 10.1002/art.42809. Epub 2024 Mar 13. Arthritis Rheumatol. 2024. PMID: 38272827
Development and Validation of a Novel Score to Predict Mortality in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: CRISTEN.
Hama N, Sunaga Y, Ochiai H, Kokaze A, Watanabe H, Kurosawa M, Azukizawa H, Asada H, Watanabe Y, Yamaguchi Y, Aihara M, Mizukawa Y, Ohyama M, Hashizume H, Nakajima S, Nomura T, Kabashima K, Tohyama M, Hasegawa A, Takahashi H, Mieno H, Ueta M, Sotozono C, Niihara H, Morita E, Brüggen MC, Feingold IM, Jeschke MG, Dodiuk-Gad RP, Oppel EM, French LE, Chen WT, Chung WH, Chu CY, Kang HR, Ingen-Housz-Oro S, Nakamura K, Sueki H, Abe R. Hama N, et al. Among authors: kurosawa m. J Allergy Clin Immunol Pract. 2023 Oct;11(10):3161-3168.e2. doi: 10.1016/j.jaip.2023.07.001. Epub 2023 Jul 8. J Allergy Clin Immunol Pract. 2023. PMID: 37429419
Japanese guidelines for the management of pemphigus.
Committee for Guidelines for the Management of Pemphigus Disease; Amagai M, Tanikawa A, Shimizu T, Hashimoto T, Ikeda S, Kurosawa M, Niizeki H, Aoyama Y, Iwatsuki K, Kitajima Y. Committee for Guidelines for the Management of Pemphigus Disease, et al. Among authors: kurosawa m. J Dermatol. 2014 Jun;41(6):471-86. doi: 10.1111/1346-8138.12486. J Dermatol. 2014. PMID: 24909210 Review.
Long-term efficacy and safety of tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: final analysis of phase IIb results.
Rai S, Kim WS, Ando K, Choi I, Izutsu K, Tsukamoto N, Maruyama D, Tsukasaki K, Kuroda J, Ando J, Hidaka M, Koh Y, Kato H, Uchida T, Yang DH, Ishitsuka K, Ishizawa K, Kim JS, Lee HG, Minami H, Eom HS, Kurosawa M, Lee JH, Lee JS, Lee WS, Nagai H, Shindo T, Yoon DH, Yoshida S, Gillings M, Onogi H, Tobinai K. Rai S, et al. Among authors: kurosawa m. Haematologica. 2024 Oct 1;109(10):3357-3362. doi: 10.3324/haematol.2023.283992. Haematologica. 2024. PMID: 38841789 Free PMC article. Clinical Trial. No abstract available.
Cervical Cancer Protection in Japan: Where Are We?
Yagi A, Ueda Y, Kakuda M, Nakagawa S, Hiramatsu K, Miyoshi A, Kobayashi E, Kimura T, Kurosawa M, Yamaguchi M, Adachi S, Kudo R, Sekine M, Suzuki Y, Sukegawa A, Ikeda S, Miyagi E, Enomoto T, Kimura T. Yagi A, et al. Among authors: kurosawa m. Vaccines (Basel). 2021 Nov 1;9(11):1263. doi: 10.3390/vaccines9111263. Vaccines (Basel). 2021. PMID: 34835194 Free PMC article. Review.
Behçet's disease and activities of daily living.
Nagano A, Takeuchi M, Horita N, Teshigawara T, Kawagoe T, Mizuki Y, Meguro A, Nakano H, Kirino Y, Takase-Minegishi K, Yoshimi R, Kurosawa M, Fukumoto T, Takeno M, Kaneko T, Mizuki N. Nagano A, et al. Among authors: kurosawa m. Rheumatology (Oxford). 2022 Mar 2;61(3):1133-1140. doi: 10.1093/rheumatology/keab499. Rheumatology (Oxford). 2022. PMID: 34146088
744 results